Hepatic oncology has particularly demanding and unique challenges. With Merit Medical’s Interventional Oncology Portfolio, you can count on reliable solutions to help you achieve the best outcomes for your patients. HepaSphere™ Microspheres (not available in the United States) deliver excellent objective response rates for embolisation of hepatocellular carcinoma and metastases to the liver.
QuadraSphere® Microspheres are cleared by the FDA for the embolization of hepatoma, hyper vascular tumors, and arteriovenous malformations (AVMs). Clinical results reflect our innovative, quality-driven, data-backed product development. Merit Medical’s interventional oncology embolics feature unique vessel lumen contact and time-saving loading profile to help you manage the challenges associated with hepatic and Interventional oncology.